Western Midstream (WES) Advances While Market Declines: Some Information for Investors

Western Midstream (WES) closed at $41.85, up 0.02%, and has outperformed the S&P 500 and its sector over the past month with a 1.16% gain. Ahead of its earnings release, analysts project a significant year-over-year EPS decline of 43.54% to $0.83, despite an anticipated 6.46% revenue increase to $945.11 million. While WES trades at a forward P/E of 12.28, a discount to its industry average of 23.89, recent analyst EPS estimates have seen a 1.64% downward revision, and its industry ranks in the bottom 36% of all sectors.

Analysis

Western Midstream (WES) presents a mixed profile for investors, characterized by recent stock price resilience juxtaposed with deteriorating forward-looking fundamentals. The stock's 1.16% gain over the past month sharply contrasts with a 1.22% loss for the Oils-Energy sector and a 7.48% loss for the S&P 500, indicating significant relative strength. However, this performance precedes an earnings release where analysts forecast a sharp 43.54% year-over-year decline in EPS to $0.83, despite a projected 6.46% increase in revenue to $945.11 million. This divergence suggests potential margin compression or rising costs, a trend reinforced by full-year estimates anticipating a 15.17% drop in earnings on a 5.21% revenue gain. Adding to the cautious outlook, the Zacks Consensus EPS estimate has been revised 1.64% lower over the last 30 days, and the stock carries a neutral #3 (Hold) rank. While its forward P/E of 12.28 appears discounted compared to the industry average of 23.89, this valuation must be considered in the context of its weak industry ranking, which falls in the bottom 36% of over 250 industries.

Key Decisions for Investors

• Investors should treat the upcoming earnings report as a critical catalyst, focusing on management's explanation for the significant disconnect between rising revenue and declining earnings projections.
• The stock's valuation discount, indicated by a forward P/E of 12.28 versus the industry's 23.89, should be viewed with caution as it may reflect the market pricing in the severe 43.54% expected EPS decline and negative analyst revisions.
• Given the conflicting signals of recent stock outperformance against a backdrop of negative earnings forecasts and a weak industry rank, maintaining a neutral position pending earnings clarification appears prudent.